AR100926A1 - IMMUNOTHERAPY AGAINST VARIOUS TUMORS OF BLOOD, IN PARTICULAR AGAINST CHRONIC LYMPHAIDE LEUKEMIA - Google Patents

IMMUNOTHERAPY AGAINST VARIOUS TUMORS OF BLOOD, IN PARTICULAR AGAINST CHRONIC LYMPHAIDE LEUKEMIA

Info

Publication number
AR100926A1
AR100926A1 ARP150101983A ARP150101983A AR100926A1 AR 100926 A1 AR100926 A1 AR 100926A1 AR P150101983 A ARP150101983 A AR P150101983A AR P150101983 A ARP150101983 A AR P150101983A AR 100926 A1 AR100926 A1 AR 100926A1
Authority
AR
Argentina
Prior art keywords
lymphaide
leukemia
blood
refers
tumors
Prior art date
Application number
ARP150101983A
Other languages
Spanish (es)
Inventor
Stevanovic Stefan
Rammensee Hans
Georg - Kowalewski Daniel
Stickel Juliane
Original Assignee
Immatics Biotechnologies Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immatics Biotechnologies Gmbh filed Critical Immatics Biotechnologies Gmbh
Publication of AR100926A1 publication Critical patent/AR100926A1/en

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La presente se refiere a péptidos, ácidos nucleicos y células destinados a la utilización en métodos inmunoterapéuticos. En particular, se refiere a la inmunoterapia contra el cáncer. También a epítopos peptídicos para linfocitos T citotóxicos (CTL) asociados a tumores, solos o en combinación con otros péptidos asociados a tumores que pueden servir como principios activos farmacéuticos en composiciones vacunales destinadas a estimular respuestas inmunitarias antitumorales. Además se refiere específicamente a varias secuencias peptídicas y sus variantes derivadas de moléculas antígenos leucocitarios humanos (HLA) de clase I y clase II de células tumorales humanas que pueden ser utilizadas en composiciones vacunales para desencadenar respuestas inmunitarias antitumorales.This refers to peptides, nucleic acids and cells intended for use in immunotherapeutic methods. In particular, it refers to immunotherapy against cancer. Also to peptide epitopes for cytotoxic T lymphocytes (CTL) associated with tumors, alone or in combination with other peptides associated with tumors that can serve as pharmaceutical active ingredients in vaccine compositions intended to stimulate antitumor immune responses. It also specifically refers to several peptide sequences and their variants derived from human leukocyte antigen (HLA) class I and class II human tumor cells that can be used in vaccine compositions to trigger antitumor immune responses.

ARP150101983A 2014-06-20 2015-06-19 IMMUNOTHERAPY AGAINST VARIOUS TUMORS OF BLOOD, IN PARTICULAR AGAINST CHRONIC LYMPHAIDE LEUKEMIA AR100926A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201462014849P 2014-06-20 2014-06-20

Publications (1)

Publication Number Publication Date
AR100926A1 true AR100926A1 (en) 2016-11-09

Family

ID=58699923

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP150101983A AR100926A1 (en) 2014-06-20 2015-06-19 IMMUNOTHERAPY AGAINST VARIOUS TUMORS OF BLOOD, IN PARTICULAR AGAINST CHRONIC LYMPHAIDE LEUKEMIA

Country Status (2)

Country Link
AR (1) AR100926A1 (en)
MA (1) MA50590A (en)

Also Published As

Publication number Publication date
MA50590A (en) 2020-09-16

Similar Documents

Publication Publication Date Title
CR20160531A (en) NEW IMMUNOTHERAPY AGAINST VARIOUS TUMORS OF BLOOD, LIKE ACUTE MYELOGEN LEUKEMIA (LMA)
CU20160060A7 (en) PEPTIDES, NUCLEIC ACIDS AND CELLS, USEFUL IN PERSONALIZED IMMUNOTHERAPY AGAINST VARIOUS CEREBRAL AND NEURONAL TUMORS
CO2018004865A2 (en) Peptides and combinations of peptides for immunotherapy against chronic lymphocytic leukemia (llc) and other cancers
CR20160018A (en) NEW IMMUNOTHERAPY AGAINST VARIOUS TUMORS LIKE CANCER OF LUNG, INCLUDING THE CARCINOMA OF PULMON AMICROCÍTICO (NSCLC)
CR20180174A (en) NEW PEPTIDES, COMBINATIONS OF PEPTIDES AND SUPPORTS FOR USE IN THE IMMUNOTHERAPEUTIC TREATMENT OF VARIOUS TYPES OF CANCER
CR20170419A (en) NEW PEPTIDES AND NEW COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST CANCER CANCER AND OTHER TYPES OF CANCER.
AR103220A1 (en) PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST HEPATOCELLULAR CARCINOMA (CHC) AND OTHER TYPES OF CANCER
TW201613956A (en) Novel immunotherapy against several tumors of the blood, in particular chronic lymphoid leukemia (CLL)
CY1124950T1 (en) INNOVATIVE IMMUNOTHERAPY AGAINST VARIOUS TUMORS SUCH AS LUNG CANCER INCLUDING SCLC
CO2017003772A2 (en) Peptides and peptide combination for use in immunotherapy against hepatocellular carcinoma (chc) and other cancers
CY1122083T1 (en) INNOVATIVE IMMUNOTHERAPY AGAINST CERTAIN BLOOD TUMORS, SUCH AS ACUTE MYELOGIC LEUKEMIA (AML)
AR100926A1 (en) IMMUNOTHERAPY AGAINST VARIOUS TUMORS OF BLOOD, IN PARTICULAR AGAINST CHRONIC LYMPHAIDE LEUKEMIA
AR118181A2 (en) IMMUNOTHERAPY AGAINST VARIOUS TUMORS SUCH AS LUNG CANCER, INCLUDING AMICROCITIC LUNG CARCINOMA (NSCLC)
AR113131A2 (en) IMMUNOTHERAPY AGAINST VARIOUS TUMORS SUCH AS LUNG CANCER, INCLUDING AMICROCITIC LUNG CARCINOMA (NSCLC)
AR101159A1 (en) IMMUNOTHERAPY AGAINST VARIOUS TUMORS OF THE BLOOD, LIKE THE ACUTE MYELOGEN LEUKEMIA (LMA)
MX2019013161A (en) Personalized immunotherapy against several neuronal and brain tumors.
EA201990696A1 (en) PERSONALIZED IMMUNOTHERAPY OF SEVERAL SPECIES OF NEURAL TUMORS AND BRAIN TUMORS

Legal Events

Date Code Title Description
FB Suspension of granting procedure